Skip to main content

Tresiba 100 units/mL (U-100) multiple-dose vial Images

Generic Name: insulin degludec

This medication has been identified as Tresiba 100 units/mL (U-100) multiple-dose vial. It is supplied by Novo Nordisk.

Tresiba is used in the treatment of diabetes, type 2; diabetes, type 1; diabetes mellitus and belongs to the drug class insulin. Risk cannot be ruled out during pregnancy. Tresiba 100 units/mL (U-100) multiple-dose vial is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Tresiba 100 units/mL (U-100) multiple-dose vial medicine

Tresiba

Generic Name
insulin degludec
Imprint
medicine
Strength
100 units/mL (U-100) multiple-dose vial
Availability
Prescription only
Drug Class
Insulin
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Novo Nordisk
National Drug Code (NDC)
00169-2662

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.